歌礼制药-B:减重不减肌药研发推进顺利,市场空间广阔
ASCLETIS(01672) 国元国际控股·2024-12-13 10:06
证 券 研 究 报 告 | --- | --- | --- | |---------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | 即时点评 | | 减重不减肌药研发 ...